Meiyu Geng Selected Research

Phosphoglycerate Mutase (Phosphoglyceromutase)

1/2020	Erratum: Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration - Erratum.
7/2017	Correction: Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
1/2017	Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration.
1/2017	Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
1/2017	Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meiyu Geng Research Topics

Disease

88	Neoplasms (Cancer) 09/2022 - 09/2006
11	Neoplasm Metastasis (Metastasis) 08/2021 - 09/2006
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
5	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2007
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2008 - 08/2004
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 11/2011
3	Lung Neoplasms (Lung Cancer) 09/2022 - 02/2015
3	Bites and Stings (Sting) 09/2022 - 11/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2017
3	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 12/2016
3	Inflammation (Inflammations) 01/2018 - 11/2011
2	Melanoma (Melanoma, Malignant) 09/2022 - 06/2017
2	Dementia (Dementias) 01/2021 - 01/2020
2	Neuroinflammatory Diseases 10/2019 - 04/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2018
1	Genetic Translocation (Chromosomal Translocation) 10/2021
1	Multiple Myeloma 10/2021
1	Cognitive Dysfunction 10/2019
1	Dysbiosis 10/2019
1	Adenocarcinoma of Lung 02/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019

Drug/Important Bio-Agent (IBA)

21	Phosphotransferases (Kinase)IBA 01/2020 - 01/2012
10	Pharmaceutical PreparationsIBA 02/2022 - 01/2005
9	Proteins (Proteins, Gene)FDA Link 09/2022 - 05/2005
8	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 07/2015
5	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 01/2020 - 01/2017
5	EnzymesIBA 10/2017 - 08/2015
5	OligosaccharidesIBA 06/2014 - 02/2005
4	SodiumIBA 02/2022 - 10/2019
4	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2016
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 03/2011
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2018 - 01/2012
4	Biological ProductsIBA 03/2018 - 01/2008
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2017 - 01/2008
4	oligomannurarate sulfateIBA 06/2014 - 09/2006
4	sulfated polymannuroguluronateIBA 04/2006 - 08/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022 - 04/2006
3	InterferonsIBA 09/2022 - 11/2021
3	CytokinesIBA 01/2019 - 01/2005
3	Serine (L-Serine)FDA Link 01/2019 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2012
3	heparanaseIBA 10/2017 - 09/2006
3	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2011
3	Polysaccharides (Glycans)IBA 07/2010 - 08/2004
3	Anti-HIV Agents (AIDS Drugs)IBA 07/2005 - 08/2004
2	Histones (Histone)IBA 09/2022 - 01/2018
2	Lysine (L-Lysine)FDA Link 09/2022 - 08/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2022 - 10/2021
2	Adenosine Triphosphate (ATP)IBA 09/2022 - 01/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 08/2022 - 11/2021
2	coactivator-associated arginine methyltransferase 1IBA 11/2021 - 01/2019
2	Histone MethyltransferasesIBA 10/2021 - 02/2015
2	undecylprodigiosinIBA 01/2020 - 01/2013
2	Amino Acids FDA Link 10/2019 - 04/2006
2	Antineoplastic Agents (Antineoplastics)IBA 03/2018 - 08/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 01/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2017 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 02/2015
2	CeramidesIBA 06/2017 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2015
2	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2017 - 11/2011
2	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 11/2015 - 12/2014
2	Actin Depolymerizing Factors (Cofilins)IBA 06/2014 - 12/2013
2	Tamoxifen FDA LinkGeneric 01/2013 - 01/2013
2	tat Gene Products (tat Protein)IBA 01/2008 - 04/2006
1	Lactate Dehydrogenase 5IBA 09/2022
1	imidazoleIBA 08/2022
1	ErbB Receptors (EGF Receptor)IBA 02/2022
1	LS-106IBA 02/2022
1	osimertinibIBA 02/2022
1	Histone-Lysine N-MethyltransferaseIBA 01/2022
1	pyrimidineIBA 01/2022
1	Arginine (L-Arginine)FDA Link 11/2021
1	TriazolesIBA 11/2021
1	Therapeutic UsesIBA 08/2021
1	Ketone BodiesIBA 11/2019
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 10/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 10/2019
1	GV-971IBA 10/2019
1	Isoleucine (L-Isoleucine)FDA Link 10/2019
1	IndazolesIBA 02/2019
1	EphrinsIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Janus KinasesIBA 01/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2019
1	Vascular Endothelial Growth FactorsIBA 06/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	tau Proteins (tau Protein)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	glumetinibIBA 01/2018

Therapy/Procedure

41	Therapeutics 09/2022 - 01/2005
5	Oral Administration 02/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
2	Immunotherapy 08/2022 - 11/2021
1	Activities of Daily Living (ADL) 01/2021
1	Aftercare (After-Treatment) 01/2019